Insulin	O
-	O
induced	O
vascular	O
endothelial	O
growth	O
factor	O
expression	O
in	O
retina	B-Multi-tissue_structure
.	O

PURPOSE	O
:	O
Clinical	O
studies	O
have	O
demonstrated	O
that	O
intensive	O
insulin	O
therapy	O
causes	O
a	O
transient	O
worsening	O
of	O
retinopathy	O
.	O

The	O
mechanisms	O
underlying	O
the	O
initial	O
insulin	O
-	O
induced	O
deterioration	O
of	O
retinal	B-Multi-tissue_structure
status	O
in	O
patients	O
with	O
diabetes	O
remain	O
unknown	O
.	O

Vascular	O
endothelial	O
growth	O
factor	O
(	O
VEGF	O
)	O
is	O
known	O
to	O
be	O
operative	O
in	O
the	O
pathogenesis	O
of	O
diabetic	O
retinopathy	O
.	O

The	O
current	O
study	O
was	O
conducted	O
to	O
characterize	O
the	O
effect	O
of	O
insulin	O
on	O
retinal	B-Multi-tissue_structure
VEGF	O
gene	O
expression	O
in	O
vitro	O
and	O
in	O
vivo	O
.	O

METHODS	O
:	O
The	O
effect	O
of	O
insulin	O
on	O
VEGF	O
expression	O
in	O
vivo	O
was	O
examined	O
by	O
in	O
situ	O
hybridization	O
studies	O
of	O
rat	O
retinal	B-Multi-tissue_structure
VEGF	O
transcripts	O
.	O

To	O
examine	O
the	O
mechanisms	O
by	O
which	O
insulin	O
regulates	O
VEGF	O
expression	O
,	O
human	O
retinal	B-Cell
pigment	I-Cell
epithelial	I-Cell
(	I-Cell
RPE	I-Cell
)	I-Cell
cells	I-Cell
were	O
exposed	O
to	O
insulin	O
,	O
and	O
VEGF	O
mRNA	O
levels	O
were	O
quantified	O
with	O
RNase	O
protection	O
assays	O
(	O
RPAs	O
)	O
.	O

Conditioned	O
media	O
from	O
insulin	O
-	O
treated	O
RPE	B-Cell
cells	I-Cell
were	O
assayed	O
for	O
VEGF	O
protein	O
and	O
capillary	B-Cell
endothelial	I-Cell
cell	I-Cell
proliferation	O
.	O

The	O
capacity	O
of	O
insulin	O
to	O
stimulate	O
the	O
VEGF	O
promoter	O
linked	O
to	O
a	O
luciferase	O
reporter	O
gene	O
was	O
characterized	O
in	O
transient	O
transfection	O
assays	O
.	O

RESULTS	O
:	O
Insulin	O
increased	O
VEGF	O
mRNA	O
levels	O
in	O
the	O
ganglion	B-Tissue
,	O
inner	B-Tissue
nuclear	I-Tissue
,	O
and	O
RPE	B-Tissue
cell	I-Tissue
layers	I-Tissue
.	O

In	O
vitro	O
,	O
insulin	O
increased	O
VEGF	O
mRNA	O
levels	O
in	O
human	O
RPE	B-Cell
cells	I-Cell
and	O
enhanced	O
VEGF	O
promoter	O
activity	O
without	O
affecting	O
transcript	O
stability	O
.	O

Insulin	O
treatment	O
also	O
increased	O
VEGF	O
protein	O
levels	O
in	O
conditioned	O
RPE	B-Cell
cell	I-Cell
media	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
with	O
a	O
median	O
effective	O
concentration	O
of	O
5	O
nM	O
.	O

The	O
insulin	O
-	O
conditioned	O
RPE	B-Cell
cell	I-Cell
media	O
stimulated	O
capillary	B-Cell
endothelial	I-Cell
cell	I-Cell
proliferation	O
,	O
an	O
effect	O
that	O
was	O
completely	O
blocked	O
by	O
anti	O
-	O
VEGF	O
neutralizing	O
antibody	O
.	O

CONCLUSIONS	O
:	O
Insulin	O
increases	O
VEGF	O
mRNA	O
and	O
secreted	O
protein	O
levels	O
in	O
RPE	B-Cell
cells	I-Cell
through	O
enhanced	O
transcription	O
of	O
the	O
VEGF	O
gene	O
.	O

Intensive	O
insulin	O
therapy	O
may	O
cause	O
a	O
transient	O
worsening	O
of	O
retinopathy	O
in	O
patients	O
with	O
diabetes	O
through	O
increased	O
retinal	B-Multi-tissue_structure
VEGF	O
gene	O
expression	O
.	O

